MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q3 2023. The put-call ratio across all filers is 2.34 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $530,550 | -35.2% | 22,500 | -27.7% | 0.00% | -50.0% |
| Q2 2023 | $818,863 | +43.1% | 31,100 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $572,240 | +18.9% | 31,100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $481,117 | -89.5% | 31,100 | -86.4% | 0.00% | -90.0% |
| Q3 2022 | $4,570,000 | +162.8% | 228,133 | +176.5% | 0.01% | +25.0% |
| Q2 2021 | $1,739,000 | +676.3% | 82,520 | +419.1% | 0.01% | +300.0% |
| Q4 2019 | $224,000 | – | 15,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |